We develop AI to help our partners overcome the challenges of drug discovery. Our discoveries help create better medicines faster.
Our AI-powered discovery portfolio includes an internally developed pipeline, JVs, academic and biopharma development partners, and is backed by prominent investors.
Atomwise developed the first and most advanced deep learning AI technology for structure-based small molecule drug discovery.
The secret to reinventing drug discovery with AI is people. We are dedicated to developing the best AI platform and using it to accelerate small molecule drug discovery with our partners.